Company profile for SciTech Development

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SciTech Development, LLC is a Michigan based oncology drug development company currently bringing to market proven cancer drugs for diseases with limited therapeutic options. Originally associated with the Karmanos Cancer Institute (KCI) and Wayne State University (WSU), SciTech was tasked with addressing the therapeutic performance limitations of fenretinide; namely, its inherently poor solubility, the associated poor bioa...
SciTech Development, LLC is a Michigan based oncology drug development company currently bringing to market proven cancer drugs for diseases with limited therapeutic options. Originally associated with the Karmanos Cancer Institute (KCI) and Wayne State University (WSU), SciTech was tasked with addressing the therapeutic performance limitations of fenretinide; namely, its inherently poor solubility, the associated poor bioavailability and the consequent inability to deliver safe and effective doses.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
SciTech Development LLC 281 Kercheval Avenue Grosse Pointe Farms, MI 48236
Telephone
Telephone
(313) 938-5517
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/scitech-development-announces-the-closing-of-oversubscribed-5-5-million-funding-round-to-continue-cancer-clinical-trials-302564946.html

PR NEWSWIRE
24 Sep 2025

https://www.prnewswire.com/news-releases/scitech-development-announces-2nd-fda-approval-of-a-phase-1-ab-ind-for-st-001-new-ind-targets-the-treatment-of-relapsedrefractory-small-cell-lung-cancer-following-its-previous-approval-in-the-treatment-of-t-cell-nhl-302421487.html

PR NEWSWIRE
08 Apr 2025

https://www.prnewswire.com/news-releases/scitech-development-advances-to-next-stage-of-clinical-trial-for-st-001-nanofenretinide-302348501.html

PR NEWSWIRE
13 Jan 2025

https://www.prnewswire.com/news-releases/scitech-development-welcomes-ken-massey-phd-as-strategic-operations-advisor-302324978.html

PR NEWSWIRE
10 Dec 2024

https://www.prnewswire.com/news-releases/scitech-development-announces-promising-preliminary-results-in-phase-1a-trial-for-t-cell-non-hodgkin-lymphoma-302320972.html

PR NEWSWIRE
03 Dec 2024

https://www.prnewswire.com/news-releases/scitech-development-inc-announces-receipt-of-drug-supply-from-the-national-cancer-institute-nci-302249654.html

PR NEWSWIRE
17 Sep 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty